CBL — Control Bionics Share News
0.000.00%
- AU$23.07m
- AU$21.61m
- AU$5.40m
Australia's Control Bionics jumps as revenue rises on faster approvals
Australia's Control Bionics drops on discounted placement
Brief: Control Bionics Seeks Trading Halt
Australia's Control Bionics gains on UK and Ireland distribution agreement
Brief: Control Bionics Says Exclusive UK And Ireland Distribution Agreement
Brief: Control Bionics Updates On Approval For Neuronode
Brief: Control Bionics Says TGA Approval Granted
Australia's Control Bionics jumps on approval for autonomous wheelchair
Brief: Control Bionics Completes Successful A$1.04M Placement
Brief: Control Bionics Seeks Trading Halt
Brief: Control Bionics Ltd Says Appointment Of Shannon Boothroyd As Chief Financial Officer
Brief: Control Bionics Signing Of A Memorandum Of Understanding With Toho Lamac
Australia's Control Bionics hits over 1-month high on registration of device in UK
Brief: Control Bionics Says Neuronode Registered With UK Medicines And Healthcare Products Regulatory Agency
Brief: Control Bionics Ltd Says Total Revenue For Half Was Up 17%
Brief: Control Bionics Says Non-Renounceable Rights Issue Offer Underwritten To Over A$1 Mln
Brief: Control Bionics Says FY Loss Attributable A$5.6 Mln
Brief: Control Bionics Says For Q4 A$1.5M Sales Revenue
Brief: Control Bionics Says Revenue For Year Expected To Be A$5.3 Million